- Home
- ANNA vs SOPH Comparison
ANNA vs SOPH Comparison
Compare ANNA & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNA
- SOPH
- Stock Information
- Founded
- ANNA 2007
- SOPH 2011
- Country
- ANNA United States
- SOPH Switzerland
- Employees
- ANNA N/A
- SOPH N/A
- Industry
- ANNA
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ANNA
- SOPH Health Care
- Exchange
- ANNA NYSE
- SOPH Nasdaq
- Market Cap
- ANNA 215.9M
- SOPH 219.8M
- IPO Year
- ANNA N/A
- SOPH 2021
- Fundamental
- Price
- ANNA $5.31
- SOPH $3.16
- Analyst Decision
- ANNA
- SOPH Buy
- Analyst Count
- ANNA 0
- SOPH 1
- Target Price
- ANNA N/A
- SOPH $7.00
- AVG Volume (30 Days)
- ANNA 31.9K
- SOPH 37.6K
- Earning Date
- ANNA 08-15-2025
- SOPH 08-05-2025
- Dividend Yield
- ANNA N/A
- SOPH N/A
- EPS Growth
- ANNA N/A
- SOPH N/A
- EPS
- ANNA N/A
- SOPH N/A
- Revenue
- ANNA $2,064,630.00
- SOPH $67,173,000.00
- Revenue This Year
- ANNA N/A
- SOPH $16.13
- Revenue Next Year
- ANNA N/A
- SOPH $23.80
- P/E Ratio
- ANNA N/A
- SOPH N/A
- Revenue Growth
- ANNA N/A
- SOPH 4.66
- 52 Week Low
- ANNA $4.36
- SOPH $2.58
- 52 Week High
- ANNA $18.70
- SOPH $4.92
- Technical
- Relative Strength Index (RSI)
- ANNA N/A
- SOPH 42.82
- Support Level
- ANNA N/A
- SOPH $3.36
- Resistance Level
- ANNA N/A
- SOPH $3.75
- Average True Range (ATR)
- ANNA 0.00
- SOPH 0.21
- MACD
- ANNA 0.00
- SOPH -0.07
- Stochastic Oscillator
- ANNA 0.00
- SOPH 9.09
About ANNA ALEANNA INC
AleAnna Inc is a developer and producer of natural gas in Italy, engaged in naturally occurring biogenic methane from conventional geological formations and carbon-negative renewable biomethane generated from farm wastes, particularly in the Po Valley of Northern Italy. It is also involved in drilling, testing, and tie-in-related activities associated with three incremental Longanesi development wells.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.